menu
    • menu

    Company profile for AAVantgarde Bio

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AAVantgarde Bio is a clinical-stage, Italian headquartered, international biotechnology company that has developed two proprietary Adeno-Associated Viral (AAV) vector platforms to address the gene therapy cargo capacity limitations of AAV vectors. This platform is being clinically validated in two Inherited Retinal Diseases; Usher1B and Stargardt disease, and the platform is expected to address the gene therapy cargo capacity ...
    AAVantgarde Bio is a clinical-stage, Italian headquartered, international biotechnology company that has developed two proprietary Adeno-Associated Viral (AAV) vector platforms to address the gene therapy cargo capacity limitations of AAV vectors. This platform is being clinically validated in two Inherited Retinal Diseases; Usher1B and Stargardt disease, and the platform is expected to address the gene therapy cargo capacity limitations of AAV vectors therefore the future pipeline could extend into many disease areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AAVantgarde BioItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Vincenzo Gioberti, 8 20123 Milano
    Telephone
    Telephone
    +39 02 83991300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aavantgardebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aavantgarde-bio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aavantgarde To Present New LUCE Ph 1/2 Data At ARVO 2026
    Aavantgarde To Present New LUCE Ph 1/2 Data At ARVO 2026

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3279732/0/en/aavantgarde-to-participate-in-arvo-2026-with-presentations-at-key-pre-events-and-new-clinical-data-from-the-luce-phase-1-2-study.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Aavantgarde Names Philip Lao Senior Vp Business Development
    Aavantgarde Names Philip Lao Senior Vp Business Development

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266452/0/en/AAVantgarde-appoints-Philip-Lao-as-Senior-Vice-President-of-Business-Development.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    AAVantgarde Completes LUCE-1 Ph 1/2 Trial Enrollment for AAVB-081
    AAVantgarde Completes LUCE-1 Ph 1/2 Trial Enrollment for AAVB-081

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219392/0/en/AAVantgarde-Completes-Enrollment-in-LUCE-1-Phase-1-2-Clinical-Trial-of-AAVB-081-for-Usher-Syndrome-Type-B-associated-Retinitis-Pigmentosa.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    AAVantgarde To Present At 44th J.P. Morgan Healthcare Conference
    AAVantgarde To Present At 44th J.P. Morgan Healthcare Conference

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215216/0/en/AAVantgarde-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Italian Biotech Raises $141M Series B To Fund Eye Gene Therapies
    Italian Biotech Raises $141M Series B To Fund Eye Gene Therapies

    04 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/italian-biotech-aavantgarde-eyes-143m-series-b-fund-retinal-disease-gene-therapy-trials

    FIERCE BIOTECH
    04 Nov 2025
    Share Share
    Aavantgarde Reveals 3 Presentations At ESGCT 2025 Conference
    Aavantgarde Reveals 3 Presentations At ESGCT 2025 Conference

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162919/0/en/AAVantgarde-announces-3-presentations-at-ESGCT-2025-annual-meeting.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search